Fusobacterium nucleatum Lipopolysaccharides Disrupt the Interaction of Siglec-7 to Sialoglycans Expressed on Mammalian Cells
Open Access
- 4 March 2026
- journal article
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (3) , 1643-1653
Abstract
Sialic acid-binding immunoglobulin-like lectins (Siglecs) are key immune receptors that bind to cell surface sialic acids, leading to modulation of the immune system. Interrupting the Siglec–sialoglycan binding in cancer has been proposed as a potential antitumor response strategy. We previously showed that colon-cancer-associated Fusobacterium nucleatum (Fn) ATCC 51191 interacts with Siglec-7 via its lipopolysaccharide (LPS), revealing Fn LPS as a new ligand for Siglec-7. Here, we used glycoengineered cells carrying sialic acid variants to investigate the capacity of LPS isolated from F. nucleatum strains to disrupt the interaction between sialic acid expressed on mammalian cells and Siglec-7. We first showed that LPS extracted from Fusobacterium polymorphum ATCC 10953, F. nucleatum ssp. animalis ATCC 51191, and F. nucleatum ssp. nucleatum ATCC 25586 strains bound to recombinant Siglec-7 in vitro, while no binding was observed with the Siglec-7R124A mutant, suggesting that the binding occurred through the carbohydrate binding V-set domain. Using glycoengineered Jurkat cells and HEK293T cells carrying modified sialic acid forms, we demonstrated that F. nucleatum LPS could significantly disrupt the binding of Siglec-7 to these cells and that this inhibition was decreased following neuraminidase treatment, confirming that the interaction between Fn LPS and Siglec-7 is carbohydrate-mediated. We further validated these data using Jurkat cells and HEK293T cells expressing high-affinity sialic acid ligands. We showed that F. nucleatum LPS significantly disrupted the binding of Siglec-7 to these cells in a specific manner. These findings offer novel insights into the development of glycomimetic approaches for limiting colon cancer progression.Keywords
Funding Information
- H2020 Marie Skłodowska-Curie Actions (956758)
- Biotechnology and Biological Sciences Research Council (BB/X011054/1)
This publication has 59 references indexed in Scilit:
- Insights into Siglec‐7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand FlexibilityAdvanced Science, 2025
- Extraction, Purification, and Chemical Degradation of LPS from Gut Microbiota Strains2023
- Structure of the O‐Antigen and the Lipid A from the Lipopolysaccharide of Fusobacterium nucleatum ATCC 51191ChemBioChem, 2020
- Structure of the LPS O-chain from Fusobacterium nucleatum strain MJR 7757 BCarbohydrate Research, 2018
- Structure of the LPS O-chain from Fusobacterium nucleatum strain 12230Carbohydrate Research, 2017
- Steering Siglec–Sialic Acid Interactions on Living Cells using Bioorthogonal ChemistryAngewandte Chemie International Edition, 2017
- The structure of the LPS O-chain of Fusobacterium nucleatum strain 25586 containing two novel monosaccharides, 2-acetamido-2,6-dideoxy- l -altrose and a 5-acetimidoylamino-3,5,9-trideoxy- gluco -non-2-ulosonic acidCarbohydrate Research, 2017
- Structure of the LPS O-chain from Fusobacterium nucleatum strain 10953, containing sialic acidCarbohydrate Research, 2017
- Novel VEGFR-2 kinase inhibitors identified by the back-to-front approachBioorganic & Medicinal Chemistry Letters, 2013
- Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec‐7‐dependent and ‐independent mechanismsEuropean Journal of Immunology, 2003